These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6291865)

  • 1. Study of the diffusion of cefotiam in the bronchial secretions.
    Bergogne-Berezin E; Berthelot G; Kafe H
    Chemotherapy; 1982; 28(5):327-33. PubMed ID: 6291865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laboratory evaluation of cefmenoxime: a new cephalosporin. In vitro and in vivo antibacterial activities and pharmacokinetic properties.
    Matsumoto K; Nagatake T; Uzuka Y; Harada T; Rikitomi N
    Chemotherapy; 1983; 29(2):80-8. PubMed ID: 6301776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Penetration of cefotaxime into bronchial secretions].
    Bergogne-Berezin E; Morel C; Pierre J; Monrocq N; Dournovo P; Benard Y
    Pathol Biol (Paris); 1982 Jun; 30(6 Pt 2):501-5. PubMed ID: 6289226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of the diffusion of cefmenoxime into the bronchial secretions.
    Serieys C; Bergogne-Berezin E; Kafe H; Bryskier A
    Chemotherapy; 1986; 32(1):1-6. PubMed ID: 3456295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Penetration of cefotaxime into bronchial secretions.
    Bergogne-Berezin E; Morel C; Pierre J; Monrocq N; Dournovo P; Benard Y
    Rev Infect Dis; 1982; 4 Suppl():S392-5. PubMed ID: 6294788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Penetration of cefsulodin into bronchial secretions.
    Bergogne-Berezin E; Berthelot G; Safran D; Even P; Kafe H
    Chemotherapy; 1984; 30(4):205-10. PubMed ID: 6744972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The penetration of macrolides into bronchial secretions.
    Pierre J; Bergogne-Berezin E; Kafe H; Dournovo P
    J Antimicrob Chemother; 1985 Jul; 16 Suppl A():217-20. PubMed ID: 4055550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Passage of cefotiam into prostatic tissue].
    Charton M; Panis G; Brisset JM; Veillon B; Vallancien G; Selles JP
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):530-2. PubMed ID: 3911149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of the extravascular distribution of cefotiam (SCE 963) by the skin blister technic].
    Bryskier A; Elbaz P; Fourtillan JB; Ortonne JP
    Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):506-8. PubMed ID: 6087248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biliary elimination of cefotiam, an experimental and clinical study.
    Brogard JM; Arnaud JP; Blickle JF; Levy P; Dorner M; Lautier F
    Chemotherapy; 1986; 32(3):222-35. PubMed ID: 3458565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic study of beta-lactam antibiotics in bronchial secretions.
    Bergogne-Berezin E; Morel C; Benard Y; Berthelot G; Kafe H
    Scand J Infect Dis Suppl; 1978; (14):267-72. PubMed ID: 279981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diffusion of cefotiam into ascitic fluid].
    Dao C; Hercelin B; Chotard Y; Veil N
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):527-9. PubMed ID: 3911148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of cefotiam in pediatric field (author's transl)].
    Iwai N; Sasaki A; Taneda Y; Inokuma K
    Jpn J Antibiot; 1981 Jun; 34(6):1002-18. PubMed ID: 6270417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical evaluation of cefotiam in children (author's transl)].
    Kobayashi Y; Morikawa Y; Haruta T; Kuroki S; Ohkura K; Fujiwara T
    Jpn J Antibiot; 1981 Jun; 34(6):994-1001. PubMed ID: 6270421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative efficacy of cefotiam, cefmenoxime, and ceftriaxone in experimental endocarditis and correlation with pharmacokinetics and in vitro efficacy.
    Pangon B; Joly V; Vallois JM; Abel L; Buré A; Brion N; Contrepois A; Carbon C
    Antimicrob Agents Chemother; 1987 Apr; 31(4):518-22. PubMed ID: 3300530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Studies on a new cephalosporin, cefotiam, in the pediatric field (author's transl)].
    Nakazawa S; Sato H; Niino K; Nakazawa S; Suzuki H; Iwasaki A; Hirama Y; Narita A; Chikaoka H; Oka S
    Jpn J Antibiot; 1981 May; 34(5):670-7. PubMed ID: 6270407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetic and clinical studies of cefotiam in the perinatal period].
    Hayasaki M; Hanabayashi T; Ri J; Takada Y; Ito K; Noda K; Iida M; Chan C; Yamada Y; Osugi S
    Jpn J Antibiot; 1986 Sep; 39(9):2497-518. PubMed ID: 3467091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [penetration of fosfomycin into bronchial secretions].
    Berthelot G; Bergogne-Berezin E; Kafe H; Daumal M; Gillon JC
    Pathol Biol (Paris); 1983 Jun; 31(6):519-21. PubMed ID: 6348660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cefotiam, a new cephalosporin. Microbiological research, preliminary evaluation of its effect on phagocytosis and clinical multicenter research].
    Di Nola F; Arione R; Fabiano A; Ferrea G; Leone G; Loy A; Negro F; Pavesio D; Salassa B; Soranzo ML
    Minerva Med; 1986 Nov; 77(45-46):2163-82. PubMed ID: 3540731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Basic and clinical studies of cefotiam in the field of pediatrics (author's transl)].
    Toyonaga Y; Kurosu Y; Hori M
    Jpn J Antibiot; 1981 May; 34(5):690-704. PubMed ID: 6270411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.